Evidence map›Paper›PMID 29152090›Full record

ArticleOncotarget2017

Wing-Yan Wong, Magnolia Muk-Lan Lee, Brandon Dow Chan, Victor Wan-San Ma, Wenchun Zhang, Timothy Tak-Chun Yip, Wing-Tak Wong, William Chi-Shing Tai

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Frontiers in pharmacology · 2022
    Pooled it
  2. Article
  3. Article
  4. Gypenosides attenuate HAmerican journal of translational research · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Traditional Chinese medicine in thyroid-associated orbitopathy.Journal of endocrinological investigation · 2023
    Review
  10. Article
  11. Frontiers in nutrition · 2022
    Article
  12. Article
  13. Activity Components fromMolecules (Basel, Switzerland) · 2021
    Article
  14. Protective Effects ofMolecules (Basel, Switzerland) · 2021
    Article
  15. Frontiers in pharmacology · 2021
    Article
  16. Article
  17. Review
  18. Nutrients · 2019
    Article
  19. Research on the Potential Mechanism of Gypenosides on Treating Thyroid-Associated Ophthalmopathy Based on Network Pharmacology.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Wing-Yan Wong *Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong S.A.R., China.
Magnolia Muk-Lan Lee *Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong S.A.R., China.
Brandon Dow Chan *Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong S.A.R., China.
Victor Wan-San MaDepartment of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong S.A.R., China.
Wenchun ZhangState Key Laboratory of Chinese Medicine and Molecular Pharmacology (Incubation), Shenzhen Research Institute of The Hong Kong Polytechnic University, Shenzhen, China.
Timothy Tak-Chun YipDepartment of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong S.A.R., China.
Wing-Tak WongDepartment of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong S.A.R., China.
William Chi-Shing TaiDepartment of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong S.A.R., China.
Hong Kong Polytechnic University · HKShenzhen Polytechnic · CNQueen Elizabeth Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent advances in the development of anti-inflammatory agents have improved their therapeutic outcome in inflammatory bowel disease (IBD), however, the presence of side effects and limited effectiveness hinder their widespread use. Therefore, novel compounds with strong anti-inflammatory efficacy are still required. In this study, we investigated the anti-inflammatory effect and potential mechanisms of

Indexed as

anti-inflammationcolitisgynostemma pentaphyllum saponinsinflammatory bowel diseasemacrophages

Identifiers

PMID29152090
PMCPMC5675642
OpenAlexW2756222159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.